Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and Memorial Sloan Kettering Cancer Center (MSK) have entered into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results